News
The Call Hop On Facility (HORIZON-WIDERA-2022- ACCESS-07) first cut-off closed on 20/04/2022 and 7 proposals have been submitted.
Evaluation results are expected to be communicated in July 2022.
Source: Funding and Tenders Portal
myOverview
Stay informed about Horizon Europe, Digital Europe & EDF, filtered on what matters to you.
Only for stakeholders located in Flanders
ESA Space Solutions has opened a call for proposals on space-enabled solutions for resilient electricity grids, in collaboration with ENTSO-E. The call supports proof-of-concept studies and pilot projects that address challenges in grid resilience and operational continuity.
Read moreThe Start2Def 2026 selection process opened on 4 November 2026. Belgian startups and small SMEs can submit proof-of-concept ideas for one of two defence-related challenges.
Read moreThe European Commission and ESA have launched a new website for the Earth System Science Initiative (ESSI). The site brings together collaborative research on climate change, biodiversity loss, ocean health and other environmental challenges. It presents participating projects, scientific alliances and emerging results from EU- and ESA-supported research.
Read moreThe launch of the 2027 calls for proposals under the Defence-related Research Action (DEFRA) programme has been postponed until Spring 2027. As a result, the information days initially scheduled for 23 and 24 November 2026 will also be postponed. A revised timeline will be communicated as soon as it becomes available.
Read moreTestimonial
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
